DEHP Study Prompts FDA To Consider Safety/Availability Of PVC Alternatives

FDA will examine the safety and availability of alternatives to devices containing the plasticizer di-2-ethylhexyl-phthalate (DEHP) before considering a risk management strategy.

More from Archive

More from Medtech Insight